For patients with poor differentiated BC, SLC39A1, SLC39A2, SLC39A3, SLC39A4 and SLC39A13 mRNA high expression indicated a poor prognosis of OS, whereas high expression of SLC39A11 suggested a better OS. This evidence concerns the gene SLC39A4 and breast cancer.